T. Muerdter

Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients

P. Ang, Y. Cheung, C. Khor, 2016, Clinical Pharmacokinetics.

Association of CYP2C19*2 and associated haplotypes with lower norendoxifen concentrations in tamoxifen-treated Asian breast cancer patients.

P. Ang, Y. Cheung, Y. Yap, 2016, British journal of clinical pharmacology.

Molybdenum Cofactor Catabolism Unravels the Physiological Role of the Drug Metabolizing Enzyme Thiopurine S‐Methyltransferase

U. Hofmann, M. Relling, W. Evans, 2022, Clinical pharmacology and therapeutics.

Cytokeratin-18 Is a Useful Serum Biomarker for Early Determination of Response of Breast Carcinomas to Chemotherapy

S. Linder, M. Toi, W. Aulitzky, 2007, Clinical Cancer Research.

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes.

Wolfgang Simon, Hiltrud Brauch, Michel Eichelbaum, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.